Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
SUBSCRIBE FOR FREE
Twitter
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine > News > Study provides motivation for European policy makers to implement comprehensive tobacco control
  • News

Study provides motivation for European policy makers to implement comprehensive tobacco control

  • 31 May 2021
  • Janet Fricker
Study provides motivation for European policy makers to implement comprehensive tobacco control
Total
0
Shares
0
0
0
0
0

Fully implementing tobacco control policies across Europe would avoid an estimated 1.65 million lung cancer cases over the next 20 years. The modelling study, published in the May issue of The Lancet Regional Health-Europe, found the largest proportion of lung cancer cases could be prevented in Austria, followed by Germany and Luxembourg. Today 31st May is World No Tobacco Day with this year’s theme ‘Commit to quit’ focused on disseminating the World Health Organisation (WHO) Framework Convention on Tobacco Control (FCTC) measures.

Action is undoubtedly needed across Europe, a view reinforced by the journal editorial accompanying the research highlighting Europe’s poor record. The editorial explores how the WHO Europe region has the highest prevalence of tobacco smoking rate among adults – 28% versus 21% globally, smoking rates among European women are more than double the global average – 19% versus 7% worldwide. Furthermore, although 50 out of 53 WHO Europe region countries have ratified the WHO FCTC  (outlining best practice national action on public smoking bans, advertising restrictions and taxes) only 10 have comprehensive public smoking bans. Only five (Albania, Moldova, Russia, Spain, and Turkey) have a complete ban on all forms of direct and indirect tobacco advertising, and only nine (Czechia, Denmark, Ireland, Luxembourg, the Netherlands, Slovakia, Sweden, and Turkey) offer best policy programmes supporting quitting.

In the study, Thomas Gredner (University of Heidelberg, Germany) and colleagues evaluated the potential of implementing comprehensive tobacco control measures across 30 European countries according to each country’s current level of tobacco control measured using the Tobacco Control Scale. The scale allocates points for six policy domains (price of cigarettes, smoke free public and workplaces, spending on public information campaigns, bans on advertising and promotion, health warning labels and standardised packaging, and treatment to help smokers quit), with a maximum potential score of 100. The investigators went on to estimate the number of future lung cancer cases that could be prevented in each country over the next 20 years by comparing current scores for tobacco control implementation with achieving implementation to the highest level of tobacco control policies.

Results show that with the highest-level implementation over the next 20 years:

  • In Europe, an estimated 1.65 million lung cancer cases (21.2%, 19.8% in men and 23.2% in women) could be prevented.
  • Potential levels of lung cancer prevention varied across different regions – 24.5% for Western Europe, 23.1% for Southern Europe, 22.5% for Eastern Europe and 12.5 % for Northern Europe.
  • 
Of all countries, the largest proportion of prevented lung cancer cases was estimated in Austria (30.9%), Germany (30.7%) and Luxembourg (30.0%).
  • In women (among whom lung cancer incidence is expected to increase) the study estimated a larger proportion of preventable lung cancer cases, ranging from 9.9 to 33.9% as compared to men, ranging from 8.6 to 28.5%.

“This information should be motivation for national and European-level policy makers to implement comprehensive tobacco control interventions including taxes, smoke-free legislation, public information campaigns, advertising bans, health warnings/ standardised packaging, and access to treatment,” write the study authors.

In an accompanying commentary, Kevin ten Haff (Erasmus MC, University Medical Center, Rotterdam, The Netherlands) highlights how risks for developing lung cancer remain elevated for decades after smoking cessation, with the result former smokers will account for a large proportion of the lung cancer burden over the next decade. “Lung cancer screening may aid in reducing the burden of lung cancer in former smokers, and may also provide opportunities to encourage smoking cessation among current smokers,” writes ten Haff.

The ‘Commit to Quit’ campaign, launched in December 2020, is a year-long WHO campaign focusing efforts on 22 high burden international  countries (including Germany, Poland, Turkey, and the Ukraine) where the majority of the world’s tobacco users live. Materials that WHO have made freely available include:

  • The QUIT CHALLENGE, providing daily notifications of tips and encouragement for up to six months to help people remain tobacco free. It is available free on WhatsApp Viber, Facebook Messenger and WeChat.
  • 
The artificial Intelligence digital health worker Florence, who has interactive conversations, with people and helps make quit plans and recommends help-lines and support apps.
  • Advocacy materials in 30 languages.
  • More than 100 reasons to quit tobacco.
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • commit to quit campaign
  • lung cancer screening
  • Quit Challenge
  • smoking cessation
  • Tobacco Control Scale
  • WHO Framework on Tobacco Control
  • World No Tobacco Day
Janet Fricker

Janet Fricker is a medical writer specialising in oncology and cardiology. After researching articles for Cancerworld she runs, swims, and eats porridge.

Previous Article
  • Delivery of Care

Pain relief is a right: building confidence in opioid use in oncology

  • 20 May 2021
  • Sophie Fessl
View Post
Next Article
  • News

Wake-up call to offer equal access to life-prolonging treatments in metastatic prostate cancer

  • 3 June 2021
  • Janet Fricker
View Post
You May Also Like
View Post
  • News

Key link identified in mechanism promoting lung metastases from breast cancer

  • Janet Fricker
  • 17 February 2025
View Post
  • News

OncoDaily Acquires CancerWorld: A New Era in Oncology Media

  • Christopher Greenberg
  • 22 January 2025
View Post
  • News

Second-generation BTK inhibitor shows promise as fixed-duration therapy in CLL

  • Janet Fricker
  • 18 December 2024
View Post
  • News

New evidence can help inform decisions on managing early-onset breast cancer linked to BRCA mutations

  • Janet Fricker
  • 18 December 2024
View Post
  • News

Gut microbiota influence effectiveness of tamoxifen in breast cancer

  • Janet Fricker
  • 6 December 2024
View Post
  • News

Radiotherapy prior to immunotherapy is the best treatment sequence for melanoma related brain metastases

  • Janet Fricker
  • 6 December 2024
View Post
  • News

Study helps solve the puzzle of checkpoint inhibitor myocarditis

  • Janet Fricker
  • 22 November 2024
View Post
  • News

Smoking cessation fundamental to first-line cancer care

  • Janet Fricker
  • 21 November 2024
search
or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Key link identified in mechanism promoting lung metastases from breast cancer
    • 17 February 2025
  • OncoDaily Acquires CancerWorld: A New Era in Oncology Media
    • 22 January 2025
  • Second-generation BTK inhibitor shows promise as fixed-duration therapy in CLL
    • 18 December 2024
  • New evidence can help inform decisions on managing early-onset breast cancer linked to BRCA mutations
    • 18 December 2024
  • Gut microbiota influence effectiveness of tamoxifen in breast cancer
    • 6 December 2024
Article
  • China’s integrated cancer care guidelines ‘reflect self-confidence’ in the field of oncology
    • 15 February 2025
  • Europe’s cancer agenda: how we keep it a priority in changing times
    • 20 December 2024
  • Humour: an essential tool in cancer care and communication
    • 18 December 2024
Social

Would you follow us ?

Contents
  • Stella Kyriakides: using her voice to improve health in Europe
    • 22 November 2024
  • Bulgarian oncologist Assia Konsoulova
    Assia Konsoulova: improving Bulgaria’s cancer system one oasis at a time
    • 8 November 2024
  • Mohit Singh and his mother Amrita: they are the protagonists of a long and ultimately unsuccessful journey across India in search of cures for her cancer
    ‘I feel guilty sometimes’: a young carer reflects on three years of a losing battle to save his mum
    • 24 October 2024
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.